Source: Eur Respir J, 57 (1) 1902426; 10.1183/13993003.02426-2019



Rating:

Share or cite this content

Citations should be made in the following way:
Anabela S. Ramalho, Eva Fürstová, Annelotte M. Vonk, Marc Ferrante, Catherine Verfaillie, Lieven Dupont, Mieke Boon, Marijke Proesmans, Jeffrey M. Beekman, Ifat Sarouk, Carlos Vazquez Cordero, Francois Vermeulen, Kris De Boeck. Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis. Eur Respir J, 57 (1) 1902426; 10.1183/13993003.02426-2019

Member's Comments

No comment yet.

Related content which might interest you: Individual treatment of cystic fibrosis by using intestinal organoids Source: International Congress 2015 – Advancing therapies for cystic fibrosis Year: 2015 Intestinal organoids to model cystic fibrosis Source: Eur Respir J, 54 (1) 1802379; 10.1183/13993003.02379-2018 Year: 2019 Targeting CFTR as a therapy for cystic fibrosis Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids Source: Eur Respir J 2016; 48: 451-458 Year: 2016 Measuring CFTR function in respiratory epithelial cell cultures: step to individualize treatments in cystic fibrosis? Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration Source: Eur Respir J, 59 (2) 2100185; 10.1183/13993003.00185-2021 Year: 2022 Investigation of the status of cystic fibrosis airway epithelial cells Source: Annual Congress 2008 - Multigenic expression analyses: a guide for diagnosis and therapy Year: 2008 Potentiating and correcting mutant CFTR in patients with cystic fibrosis Source: Eur Respir Monogr 2014; 64: 129-149 Year: 2014 CFTR: cystic fibrosis and beyond Source: Eur Respir J 2014; 44: 1042-1054 Year: 2014 The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model Source: Eur Respir J, 52 (6) 1801133; 10.1183/13993003.01133-2018 Year: 2018 Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function Source: Eur Respir J, 52 (3) 1702529; 10.1183/13993003.02529-2017 Year: 2018 Improvement of defective cystic fibrosis airway epithelial wound repair after CFTR rescue Source: Eur Respir J 2012; 40: 1390-1400 Year: 2012 Cystic fibrosis and intestinal organoids Source: ERN-LUNG 2021: Cystic fibrosis and intestinal organoids Year: 2021 Atypical cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38 Year: 2006 Peptide transport mechanisms in cystic fibrosis and normal human lung Source: Eur Respir J 2001; 18: Suppl. 33, 76s Year: 2001 Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages Source: Eur Respir J, 57 (6) 2003502; 10.1183/13993003.03502-2020 Year: 2021 Cystic fibrosis transmembrane conductance regulator pharmacotherapy Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=88 Year: 2006 Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis Source: Eur Respir Rev 2013; 22: 58-65 Year: 2013